Metcalf v. Felec Services

784 P.2d 1386, 1990 Alas. LEXIS 2, 1990 WL 985
CourtAlaska Supreme Court
DecidedJanuary 5, 1990
DocketS-2790
StatusPublished
Cited by8 cases

This text of 784 P.2d 1386 (Metcalf v. Felec Services) is published on Counsel Stack Legal Research, covering Alaska Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Metcalf v. Felec Services, 784 P.2d 1386, 1990 Alas. LEXIS 2, 1990 WL 985 (Ala. 1990).

Opinion

*1387 OPINION

COMPTON, Justice.

This case presents two issues. The first is whether the Alaska Workers’ Compensation Board (Board) correctly held that Edward K. Metcalf had unreasonably refused treatment after suffering a head injury resulting in recurring headaches. The second issue, raised sua sponte by this court, is whether the Board has the statutory authority to ratify an employer’s unilateral act of suspending benefits when the employer believes the employee is unreasonably refusing medical treatment.

I. FACTUAL AND PROCEDURAL BACKGROUND

On July 22,1982, Metcalf struck his head against a stationary forklift while working for Felec Services (Felec) as a pipefitter. Following his injury, Metcalf began to complain of a series of recurring headaches. Metcalf was initially diagnosed as suffering from a combination of depression and post-concussion syndrome. In the course of seeing numerous medical professionals, Metcalf has steadfastly refused prescribed treatment. Metcalf’s refusal consists primarily of a near total unwillingness to take any recommended prescription medicine. Metcalf has also refused several diagnostic procedures, including CAT scans with and without dye and a digital subtraction angio-gram (DSA).

The diagnostic procedures were recommended by Dr. Alpha, a neurologist, to see if there was (or was not) some underlying physical reason for Metcalf’s condition. Dr. Alpha testified that the risk of any adverse reaction to a CAT scan with dye, including slight reactions such as hives, was one in 2,000, with the chance of any serious reaction being far less. Dr. Alpha also testified there was no possibility of side effects from a CAT scan without dye and the total amount of radioactivity exposure would be equal to that involved in a cross-country plane flight. Metcalf refused to submit to a CAT scan, given this knowledge.

Dr. Kastella described the DSA as involving the insertion of a catheter into the heart through a vein. Dye is then injected. Dr. Kastella estimated the risk of death as a fraction of one percent.

Metcalf also refused proffered prescription medications that might have alleviated his headaches, including anti-depressants and anti-inflammatories (e.g. aspirin, Motrin). Dr. Cates testified that none of these drugs posed any significant risk of serious side-effects. Dr. Alpha agreed, and further testified that any minor side-effects which might result were easily controllable. Dr. Kastella offered similar testimony. All physicians agreed that the medications would likely alleviate Metcalf’s symptoms while time healed their cajise, assuming that they in fact had an organic root.

Upon learning of Metcalf’s disagreements with his doctors, his employer/insurer, Felec, unilaterally suspended his benefits on the ground that he was unreasonably refusing medical treatment effective January 6, 1983. The Board, by order dated July 31, 1986 determined that although Metcalf’s injury was compensable, he had unreasonably refused medical treatment within the meaning of AS 23.30.095(d). The Board also ruled that Felec need only resume paying compensation to Metcalf should he cease his refusal to follow “a reasonable medical regimen prescribed by the neurologist of his choice.... ”

Metcalf filed a “Request for Reconsideration” of the Board’s decision on June 15, 1987. The Board noted that the Alaska Workers’ Compensation Act (AWCA) does not provide for reconsideration of prior decisions. See AS 23.30.130. The Board treated Metcalf’s petition as a request for modification under AS 23.30.130. The Board then denied his petition. The superi- or court, sitting as an intermediate appellate court, AS 23.30.125; Appellate Rule 601, affirmed. Metcalf appeals.

II. DISCUSSION

A. THE BOARD’S CONCLUSION THAT METCALF UNREASONABLY REFUSED TO ACCEPT MEDICAL TREATMENT IS SUPPORTED BY SUBSTANTIAL EVIDENCE.

The Board relied on AS 23.30.095(d) of AWCA:

*1388 If at any time during the period the employee unreasonably refuses to submit to medical or surgical treatment, the board may by order suspend the payment of further compensation while the refusal continues, and no compensation may be paid at any time during the period of suspension, unless the circumstances justified the refusal.

Because this appeal stems from the Board's denial of modification, not the Board’s original decision, we decide only whether “substantial evidence” exists in the record as a whole from which the Board could conclude that Metcalf’s refusal of treatment is unreasonable. Cf. Fluor Alaska, Inc. v. Mendoza, 616 P.2d 25, 27-28 (Alaska 1980); Delaney v. Alaska Airlines, 693 P.2d 859, 863 (Alaska 1985). See also Interior Paint Co. v. Rodgers, 522 P.2d 164, 169 (Alaska 1974) (appeal from agency denial of modification is not to become a “back-door route to retrying a case”). We do not reweigh the evidence, but determine whether there is substantial evidence in light of the whole record that a reasonable mind might accept as adequate to support the Board’s conclusion. Delaney, 693 P.2d at 863; Miller v. ITT Arctic Services, 577 P.2d 1044, 1046 (Alaska 1978).

Factors to be used in determining the reasonableness of treatment refusal include the risk and seriousness of side effects, the chance of cure or improvement, and any first-hand negative experience or observations of the patient, regarding either this procedure or medical care in general. Fluor Alaska, Inc., 616 P.2d at 27-29.

With these principles in mind, we conclude that there is substantial evidence supporting the Board’s determination that Metcalf unreasonably refused treatment. No major, life-threatening surgery was proposed. The specific evidence relied upon by the Board included the unanimous testimony of several physicians concerning the substantial unlikelihood of negative side effects from the recommended medication, and the ability to substitute alternative compounds if side effects were experienced. Although none of the physicians stated the treatment could cure Metcalf’s disability, all manifested a belief that his problems could likely be at least partially alleviated by medication. Furthermore, it is uncontradicted that Metcalf had no negative first-hand experience with any of the treatments suggested.

B. PRE-ORDER NON-PAYMENT OF METCALF’S BENEFITS.

Upon learning of some of Metcalf’s refusals of treatment, Felec suspended his benefits effective January 6, 1983. There was no Board involvement in Felec’s action. The Board did not address the issue until its order dated July 31, 1986, in which it ruled that Felec would only have to resume paying benefits if and when Metcalf ceased his refusal to follow “a reasonable medical regimen prescribed by the neurologist of his choice....”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Justice v. RMH Aero Logging, Inc.
42 P.3d 549 (Alaska Supreme Court, 2002)
Hodges v. Alaska Constructors, Inc.
957 P.2d 957 (Alaska Supreme Court, 1998)
Metcalf v. Felec Services
938 P.2d 1023 (Alaska Supreme Court, 1997)
Gilmore v. Alaska Workers' Compensation Board
882 P.2d 922 (Alaska Supreme Court, 1994)
Hulsey v. Johnson & Holen
814 P.2d 327 (Alaska Supreme Court, 1991)
Houston Contracting, Inc. v. Phillips
812 P.2d 598 (Alaska Supreme Court, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
784 P.2d 1386, 1990 Alas. LEXIS 2, 1990 WL 985, Counsel Stack Legal Research, https://law.counselstack.com/opinion/metcalf-v-felec-services-alaska-1990.